JP2006522834A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006522834A5 JP2006522834A5 JP2006510082A JP2006510082A JP2006522834A5 JP 2006522834 A5 JP2006522834 A5 JP 2006522834A5 JP 2006510082 A JP2006510082 A JP 2006510082A JP 2006510082 A JP2006510082 A JP 2006510082A JP 2006522834 A5 JP2006522834 A5 JP 2006522834A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- composition
- disorder
- pain
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46157103P | 2003-04-09 | 2003-04-09 | |
| PCT/US2004/011668 WO2004091633A1 (en) | 2003-04-09 | 2004-04-07 | Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.o]non-1 (7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006522834A JP2006522834A (ja) | 2006-10-05 |
| JP2006522834A5 true JP2006522834A5 (https=) | 2007-06-14 |
Family
ID=33299836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006510082A Pending JP2006522834A (ja) | 2003-04-09 | 2004-04-07 | ［２−（８，９−ジオキソ−２，６−ジアザビシクロ［５．２．０］ノナ−１（７）−エン−２−イル）アルキル］ホスホン酸および誘導体の鼻腔内投与用医薬組成物およびその使用法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20050004079A1 (https=) |
| EP (1) | EP1622625A1 (https=) |
| JP (1) | JP2006522834A (https=) |
| CN (1) | CN1802161A (https=) |
| AR (1) | AR044014A1 (https=) |
| AU (1) | AU2004229567A1 (https=) |
| BR (1) | BRPI0409088A (https=) |
| CA (1) | CA2521394A1 (https=) |
| CL (1) | CL2004000765A1 (https=) |
| MX (1) | MXPA05010763A (https=) |
| TW (1) | TW200503732A (https=) |
| WO (1) | WO2004091633A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2521313A1 (en) * | 2003-04-09 | 2004-10-28 | Wyeth | Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.o)non-1(7)-3n-2-yl)-al kyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists |
| US20050142192A1 (en) * | 2003-10-15 | 2005-06-30 | Wyeth | Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives |
| GT200400213A (es) * | 2003-10-22 | 2007-09-05 | Metodos para la preparacion del acido {2-[(8,9)-dioxo-2,6-diaza-biciclo[5.2.0]-non-1(7)-en-2-il]etil} fosfonico y esteres del mismo | |
| EP2195031A1 (en) * | 2007-08-27 | 2010-06-16 | Wyeth a Corporation of the State of Delaware | Compositions and methods employing nmda antagonists for achieving an anesthetic-sparing effect |
| US8784872B2 (en) | 2007-11-19 | 2014-07-22 | Comgenrx, Inc. | Formulation for decreasing tobacco, alcohol, drug or food consumption |
| US20090130048A1 (en) * | 2007-11-19 | 2009-05-21 | Oronsky Bryan Todd | Topical Composition for Treating Pain |
| WO2009158667A2 (en) * | 2008-06-27 | 2009-12-30 | Comgenrx, Inc. | Povidone compositions for wound healing |
| US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| HK1218720A1 (zh) | 2013-04-30 | 2017-03-10 | 欧缇托匹克公司 | 干粉制剂及使用方法 |
| US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
| KR102681843B1 (ko) | 2017-09-22 | 2024-07-05 | 벡추라 인코포레이티드 | 스테아르산마그네슘을 갖는 건조 분말 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5624898A (en) * | 1989-12-05 | 1997-04-29 | Ramsey Foundation | Method for administering neurologic agents to the brain |
| US5168103A (en) * | 1991-01-22 | 1992-12-01 | American Home Products Corporation | [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl) amino]alkyl]-acid derivatives |
| US5124319A (en) * | 1991-10-11 | 1992-06-23 | American Home Products Corporation | Benzimidazole phosphono-amino acids |
| TW427904B (en) * | 1995-12-07 | 2001-04-01 | American Home Prod | Neuroprotective agents |
| US5990307A (en) * | 1997-08-01 | 1999-11-23 | American Home Products Corporation | Process for the preparation of [2-((8.9)-Dioxo-2,6-Diazabicyclo [5.2.0]-Non-1(7)-en-2yl) Ethyl]Phosphonic acid |
| US6225343B1 (en) * | 1999-06-16 | 2001-05-01 | Nastech Pharmaceutical Company, Inc. | Compositions and methods comprising morphine gluconate |
| UA78529C2 (en) * | 2001-10-10 | 2007-04-10 | Wyeth Corp | Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain |
| US20040082543A1 (en) * | 2002-10-29 | 2004-04-29 | Pharmacia Corporation | Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain |
| US20050142192A1 (en) * | 2003-10-15 | 2005-06-30 | Wyeth | Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives |
| GT200400213A (es) * | 2003-10-22 | 2007-09-05 | Metodos para la preparacion del acido {2-[(8,9)-dioxo-2,6-diaza-biciclo[5.2.0]-non-1(7)-en-2-il]etil} fosfonico y esteres del mismo |
-
2004
- 2004-04-07 EP EP04759562A patent/EP1622625A1/en not_active Withdrawn
- 2004-04-07 JP JP2006510082A patent/JP2006522834A/ja active Pending
- 2004-04-07 CN CNA2004800159192A patent/CN1802161A/zh active Pending
- 2004-04-07 AU AU2004229567A patent/AU2004229567A1/en not_active Abandoned
- 2004-04-07 BR BRPI0409088-8A patent/BRPI0409088A/pt not_active IP Right Cessation
- 2004-04-07 US US10/820,215 patent/US20050004079A1/en not_active Abandoned
- 2004-04-07 MX MXPA05010763A patent/MXPA05010763A/es unknown
- 2004-04-07 WO PCT/US2004/011668 patent/WO2004091633A1/en not_active Ceased
- 2004-04-07 CA CA002521394A patent/CA2521394A1/en not_active Abandoned
- 2004-04-07 AR ARP040101200A patent/AR044014A1/es not_active Application Discontinuation
- 2004-04-08 CL CL200400765A patent/CL2004000765A1/es unknown
- 2004-04-08 TW TW093109671A patent/TW200503732A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006523694A5 (https=) | ||
| EP3478679B1 (en) | 5,7-dihydro-pyrrolo-pyridine derivatives for treating neurological and neurodegenerative diseases | |
| TWI404721B (zh) | 胺基－雜環化合物 | |
| JP5629324B2 (ja) | ピロロ［２，３−ｄ］ピリミジン化合物 | |
| CN107592864B (zh) | 用于治疗和预防病毒感染的新的取代的氨基噻唑并嘧啶二酮 | |
| US11198692B2 (en) | Dihydro-pyrrolo-pyridine derivatives | |
| JP2006522834A5 (https=) | ||
| ES2461967T3 (es) | Compuestos de pirrolo[2,3-d]pirimidina | |
| KR101612642B1 (ko) | 테노포비어 알라펜아미드 헤미푸마레이트 | |
| JP2020528062A (ja) | ピペラジンヘテロアリール誘導体、その製造方法、およびその医薬での使用 | |
| ES2750655T3 (es) | Derivados de pirrolo[2,3-d]pirimidina útiles para inhibir la Janus cinasa | |
| JP2013501056A (ja) | ウイルス感染およびウイルス誘発腫瘍を治療する組成物および方法 | |
| JP2006507220A5 (https=) | ||
| JP2010509373A5 (https=) | ||
| JP2011506588A (ja) | 抗がん剤としての３−置換−４−オキソ−３，４−ジヒドロ−イミダゾ−［５，１−ｄ］［１，２，３，５］−テトラジン−８−カルボン酸アミド | |
| JP2016507581A (ja) | Ｃｎｓおよび他の障害を治療するための、ｐｄｅ４アイソザイムの阻害薬としてのアザベンゾイミダゾール化合物 | |
| TW202003491A (zh) | 哌嗪氮雜螺衍生物 | |
| JP2701952B2 (ja) | Ｎ‐複素環プロピリデン‐１，１‐ビスホスホン酸、その製法および薬剤組成物 | |
| JP2017512803A (ja) | ガンマセクレターゼモジュレーターとしてのクロメンおよび１，１ａ，２，７Ｂ−テトラヒドロシクロプロパ［Ｃ］クロメンピリドピラジンジオン | |
| WO2009023126A2 (en) | Bicyclic amides for enhancing glutamatergic synaptic responses | |
| JP2024536863A (ja) | イミダゾピリダジンｉｌ－１７阻害剤化合物 | |
| JP2020510041A5 (https=) | ||
| JP2016531880A (ja) | ガンマセクレターゼモジュレーターとしての新規二環式ピリジノン | |
| CN1131669A (zh) | 光学活性苯并硫杂庚英衍生物，其制备方法和用途 | |
| EP0644877B1 (en) | Substituted-hexahydrobenzo a phenanthridines |